HOME >> BIOLOGY >> NEWS
Loblolly pine open for genetic engineering, research shows

COLLEGE STATION - The nation's most important commercial pine tree - the loblolly - has been successfully genetically engineered, researchers at the Texas Agricultural Experiment Station report in the journal Molecular Breeding.

The study, which proves a concept already demonstrated on many other plant species, will lead to further research that ultimately will enable scientists to improve the native southern pine with such traits as drought tolerance and disease- and pest-resistance, according to lead researcher Dr. Jean Gould, an Experiment Station molecular biologist.

"Loblolly pine has been challenging to genetically engineer because the genotype is very difficult to regenerate into plants in tissue culture," said Gould.

The transformation was done with a marker gene merely to prove that such genetic transfer could be done and that plants carrying the gene could be regenerated.

Gould's method for transforming plants - using a plant's meristem region for inoculation with Agrobacterium - was patented by the Experiment Station in 1992. The first plants transformed using this method were petunia and corn, followed by cotton and rice. She said using a plant meristem for transformation, rather than the traditional callus method, is a quicker and more universal way to transform plants because plant regeneration is simplified. In addition, the callus method does not work for many types of plants.

Loblolly pines dominate about 29 million acres in the southern United States, according to the U.S. Forest Service. The species grows rapidly as a young tree and lives about 75 years, but does not reach reproductive maturity for as many as 10 years after germination - meaning that traditional breeding programs would take decades to accomplish any improvements for the tree.

"While some crop plants have been selectively bred for more than 10,000 years, programs for the genetic improvement of pine are less than 100 years old
'"/>

Contact: Dr. Jean Gould
gould@tamu.edu
979-845-5078
Texas A&M University - Agricultural Communications
5-Sep-2002


Page: 1 2

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Rare childhood genetic syndrome identified
3. New research shows plants can shuffle and paste gene pieces to generate genetic diversity
4. Scientists decipher genetic code of biothreat pathogen
5. Chemical genetics identifies SARS inhibitors
6. 22nd amino acid synthesized and added to genetic code of e. coli bacteria
7. The impact of genetic variations on the treatment of early rheumatoid arthritis
8. Adaptive changes in the genome may provide insight into the genetics of complex disease
9. New genetic hypothesis for the cause of autism
10. Fossils reveal direct link between global warming and genetic diversity in wildlife
11. A genetic disorder yields insight into genes and cognition

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2019)... ... March 29, 2019 , ... GenCure has selected ... cell therapy facility. The new facility, which will anchor the VelocityTX innovation center ... the art manufacturing capabilities to support clinical cell therapy trials. GenCure is a ...
(Date:3/25/2019)... ... March 25, 2019 , ... Ambry Genetics ... genetic testing, today announced a new laboratory services agreement with Clovis Oncology Inc., ... Through this laboratory services agreement, Ambry Genetics and Clovis Oncology seek to ...
(Date:3/19/2019)... , ... March 19, 2019 , ... ... EMulate Therapeutics, Inc. The name change is effective immediately for the ... other serious diseases. , In making the announcement, Chris Rivera, Chief Executive ...
Breaking Biology News(10 mins):
(Date:4/9/2019)... ... 09, 2019 , ... The American Society of Gene & Cell Therapy ... including a new addition to the presidential line of succession, at the 22nd ... Society's leadership team for a three-year term (2019-2021). , All five incoming members of ...
(Date:4/8/2019)... (PRWEB) , ... April 09, 2019 , ... ... disease, the innovative non-profit research center Chan Zuckerberg Biohub (CZ Biohub) has chosen ... of antibody repertoires is part of CZ Biohub’s efforts to establish new approaches ...
(Date:3/29/2019)... ... March 28, 2019 , ... Specific Diagnostics announced ... proceeded with a second stage of funding for Specific’s Reveal™ rapid antibiotic susceptibility ... top of the $1.7 million already awarded by CARB-X. The additional $1.7M will ...
(Date:3/27/2019)... ... 27, 2019 , ... Lachman is sponsoring the event on April 1-4, where ... Ireland. The executive team on site will be available to discuss strategies and tactics ... agenda this year. , Executives from Lachman participating at this year’s conference include Fran ...
Breaking Biology Technology:
Cached News: